Skip to main content
Clinical Trials/CTRI/2018/04/013444
CTRI/2018/04/013444
Not yet recruiting
未知

A Pilot study to assess the effect of melatonin on sleep and daily activity in patients with Stable COPD

Artemis Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Moderate and severe stable COPD.
Sponsor
Artemis Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Artemis Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with or without smoking history along with the diagnosis of moderate to severe COPD along with the treatment of LABA/LAMA or LABA/ICS and LAMA
  • 2\.Patients who have not had an exacerbation of COPD for at least 6 wks
  • 3\. Willing to give consent

Exclusion Criteria

  • 1\.Concurrent Obstructive Sleep Apnoea
  • 2\.Heart failure
  • 3\.Uncontrolled diabetes
  • 4\.Primary insomnia
  • 5\.Any other pulmonary disease
  • 6\.Patients who exacerbate during study
  • participation
  • 7\.Patients on Long term Oxygen therapy
  • 8\.Patients who are on BIPAP/CPAP
  • 9\.Patients who are on Sleeping medications (hypnotics/opioids, pain killers\-pregabalin etc)

Outcomes

Primary Outcomes

Not specified

Similar Trials